Hydrogen Sulfide: An Emerging Precision Strategy for Gas Therapy

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Gas Therapy

Background:

• Hydrogen sulfide (H2S) is a key signaling molecule with diverse physiological roles.
• Nanotechnology enables the development of stimuli-responsive nanomaterials for targeted drug delivery.
• H2S-related nanomedicines represent a novel therapeutic frontier.

Purpose of the Study:

• To review the latest advancements in H2S-responsive nanomedicines.
• To highlight H2S-based gas therapy and synergistic treatments for cancer.
• To discuss imaging techniques and clinical translation challenges for H2S nanotherapeutics.

Main Methods:

• Literature review of recent research on H2S nanomedicines.
• Analysis of studies focusing on H2S-mediated gas therapy and combination therapies.
• Examination of imaging modalities for H2S monitoring and discussion of biosafety.

Main Results:

• H2S-responsive nanomaterials show promise for precision gas therapy.
• Synergistic therapies combining H2S with chemotherapy, PDT, PTT, and CDT are effective against cancer.
• Various imaging techniques allow real-time H2S monitoring in biological systems.

Conclusions:

• H2S nanomedicines offer significant potential for cancer treatment and diagnosis.
• Further research is needed to address biosafety and facilitate clinical translation.
• Interdisciplinary research in H2S chemistry, biology, and nanomedicine is crucial for future progress.